Tivic Health Expands Clinical Study of Post-Operative Pain in Nasal and Sinus Surgeries

Author's Avatar
Apr 19, 2023

Tivic+Health%26reg%3B+Systems%2C+Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that it has expanded its post-operative pain clinical study to include Otolaryngology and Facial Plastic Surgery patients. This study aims to investigate the potential benefits of a drug-free alternative to traditional post-operative pain management methods.